Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05422898 · ClinicalTrials.gov registry record · NA

Discussing COVID-19 Vaccines in Private Facebook Groups

A NA study of COVID-19, sponsored by George Washington University.

Completed
Registry status
NA
Development phase
508
Enrollment target
1
Study location

NCT05422898 is a NA study of COVID-19 that has completed, run by George Washington University. The registered enrollment target is 508 participants, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05422898, a NA study of COVID-19, has completed, sponsored by George Washington University.

COMPLETED
Registry status
NA
Development phase
508 participants
Enrollment target
1
Study location

Study Summary

As the COVID-19 pandemic persists, a sizable proportion of the U.S. population remains unvaccinated and at high risk of death and serious illness from COVID-19. Vaccine hesitancy, fueled by the proliferation of vaccine misinformation on social media, is one factor contributing to lack of vaccination. Current attempts to overcome vaccine misinformation focus on correcting or debunking falsehoods. Although debunking strategies are important components to any public health campaign, communications must also address rationales for vaccine hesitancy that vary among individuals and communities, and directly address the gist of their concerns in an empathetic, non-judgmental manner. We will conduct a randomized controlled trial to test the effectiveness of empathic, relationship-building interactions relative to standard provision of information on social media to address COVID-19 vaccine hesitancy.

Conditions Studied

Interventions

  • BEHAVIORAL Gist messages on COVID-19 vaccination
  • BEHAVIORAL COVID-19 vaccine information

Study Locations (1)

District of Columbia

  • George Washington University - Washington D.C.

Trial Details

FieldValue
Enrollment Target 508 participants
Start Date 2022-01-17
Est. Completion 2022-04-04
Phase NA

Sponsor

George Washington University

133 total trials

What the Registry Record Tells You About NCT05422898

The ClinicalTrials.gov registry entry for NCT05422898 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 508 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Gist messages on COVID-19 vaccination is the first listed.

NCT05422898 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT05422898 about?

NCT05422898 is a clinical study titled "Discussing COVID-19 Vaccines in Private Facebook Groups". As the COVID-19 pandemic persists, a sizable proportion of the U.S. population remains unvaccinated and at high risk of death and serious illness from COVID-19. Vaccine hesitancy, fueled by the proliferation of vaccine misinformation on social media, is one factor contributing to lack of vaccination...

What is the current status of trial NCT05422898?

This trial is currently completed. It is a NA study. The enrollment target is 508 participants. The study started on 2022-01-17. Estimated completion is 2022-04-04.

What conditions does trial NCT05422898 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT05422898?

The interventions under investigation include: Gist messages on COVID-19 vaccination (BEHAVIORAL), COVID-19 vaccine information (BEHAVIORAL).

Who is sponsoring clinical trial NCT05422898?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05422898 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.